Day: February 11, 2020

OAKLAND, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) — California BanCorp (OTCQX:CALB), the holding company for California Bank of Commerce (CBC), has further expanded its Northern California presence with the addition of Michael Nicita as Executive Vice President and Senior Credit Administrator. Nicita will be based out of the Sacramento office and will be responsible for overseeing high-quality credit underwriting.“We are thrilled to have Mike join us,” said Scott Myers, Senior Executive Vice President and Chief Lending Officer. “He joins our team with experience in agricultural lending, which adds to the bank’s already well-established expertise in the manufacturing, contracting, professional services, dental and veterinary industries.”Nicita has more than two decades of experience in commercial banking with an extensive background...

THIS MEDIA RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, Feb. 11, 2020 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (RSI) announces that its Board of Directors has authorized a declaration of a quarterly dividend of $0.09 per share to be paid to Shareholders of record on March 27, 2020, payable on or before April 21, 2020. This is an eligible dividend for income tax purposes.For further information:Ms. Manon LacroixVice President of Finance, Chief Financial Officer & SecretaryLantic Inc.Tel: (514) 940-4350Website: www.lanticrogers.com

LE PRÉSENT COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE DISSÉMINATION DES ÉTATS-UNIS NI ÊTRE PUBLIÉ AUX ÉTATS-UNISMONTRÉAL, 11 févr. 2020 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (RSI) annonce que son Conseil d’administration a autorisé la déclaration d’un dividende trimestriel de 0.09$ par action aux actionnaires inscrits au 27 mars 2020, à être payé, le ou avant le 21 avril 2020.  Il s’agit d’un dividende admissible pour fins fiscales.Pour de plus amples renseignements :Mme Manon LacroixVice présidente des finances, chef de la direction financière et secrétaireLantic Inc.Tel: (514) 940-4350Site web http://www.lanticrogers.com

HIGHER ADJUSTED GROSS MARGIN AND ADJUSTED GROSS MARGIN RATE FOR SUGARADJUSTED EBITDA COMPARABLE TO PRIOR YEARMONTREAL, Feb. 11, 2020 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Company” or “Rogers”) (TSX: RSI) today reported its first quarter fiscal 2020 results. The Company recorded adjusted EBITDA (1) of $30.2 million for the first quarter of fiscal 2020, in line with the comparable period last year.“During the first quarter the business completed a detailed supply chain plan, which will deliver our domestic customers all of their sugar needs, despite having harvested half of our expected volume in Taber.” said John Holliday, President and Chief Executive Officer of Rogers and Lantic Inc. “Having gone through the exercise, we are confident in our ability to produce the expected sales volume, while minimizing the financial impact...

AUGMENTATION DE LA MARGE BRUTE AJUSTÉE ET DU TAUX DE LA MARGE BRUTE AJUSTÉE DU SECTEUR DU SUCREMONTRÉAL, 11 févr. 2020 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (la « Société » ou « Rogers ») (TSX : RSI) annonce aujourd’hui ses résultats du premier trimestre de l’exercice 2020. La Société a inscrit un BAIIA ajusté1) de 30,2 millions de dollars pour le premier trimestre de l’exercice 2020, ce qui est similaire au résultat obtenu pour le trimestre correspondant de l’exercice précédent.« Au cours du premier trimestre, nous avons achevé notre plan détaillé visant la chaîne d’approvisionnement qui nous permettra de répondre à tous les besoins de sucre de nos clients du marché domestique, malgré le fait que le volume de la récolte de Taber correspond seulement à la moitié de ce que nous avions prévu », a déclaré John Holliday, président et...

PROBUPHINE® is also listed for reimbursement through the Non-Insured Health Benefit (NIHB) and Veteran Affairs Canada drug plansPROBUPHINE® is the first and only buprenorphine implant approved in Canada for the long-term maintenance management of opioid dependence in patients clinically stabilized on no more than 8 mg of sublingual buprenorphine in combination with counseling and psychosocial support.1MONTREAL, Feb. 11, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, announced today that PROBUPHINE®, the first and only subdermal implant approved in Canada, is now additionally publicly funded in Quebec, New Brunswick, Newfoundland and Nova Scotia for the management of opioid dependence in patients clinically stabilized on no more...

PROBUPHINE® est également remboursé par les régimes d’assurance-médicaments des Services de santé non assurés (SSNA) et d’Anciens Combattants Canada.PROBUPHINE® est le premier et unique implant de buprénorphine approuvé au Canada pour le traitement d’entretien à long terme de la dépendance aux opioïdes chez les patients cliniquement stabilisés avec un maximum de 8 mg de buprénorphine sublinguale, en association avec des services-conseils et un soutien psychosocial.1MONTRÉAL, 11 févr. 2020 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou « la Société »), société pharmaceutique spécialisée et chef de file au Canada, a annoncé aujourd’hui que PROBUPHINE®, le premier et l’unique implant sous-cutané approuvé au Canada, est désormais disponible en accès public grâce au financement supplémentaire du Québec, du Nouveau-Brunswick,...

LINCOLN, Neb., Feb. 11, 2020 (GLOBE NEWSWIRE) — National Research Corporation (NASDAQ:NRC) today announced 2019 fourth quarter and year-end financial results.Fourth quarter 2019 compared to the fourth quarter 2018:Total Contract Value increased to $144.8 million, up 10%Revenue increased 6% to $32.6 millionOperating Income increased 27% to $12.0 million2019 calendar year results compared to 2018:Net New Sales of $27.7 million, up 18%Revenue increased 7% to $128.0 millionOperating Income increased 22% to $43.0 millionVoice of the Customer platform contract value surpassed $100 million, a 31% increaseCommenting on recent performance, Michael D. Hays, chief executive officer of National Research Corporation, said, “Our performance throughout the year reflects strong gains across the continuum of care where we witnessed growth in new customer...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREINTORONTO, Feb. 11, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”), a cannabis life sciences company focused on novel cannabinoid-based treatments for rare inflammatory diseases, is pleased to announce that it has engaged Hampton Securities Limited, as sole lead agent (the “Agent”), in connection with a private placement offering, on a “commercially reasonable efforts” basis, of up to 40,000,000 units of Revive (the “Units”) at a price of $0.05 per Unit (the “Unit Price”) for gross proceeds of up to $2,000,000 (the “Offering”).Each Unit shall consist of one common share (“Share”) in the capital of the Company and one common share purchase warrant (“Warrant”)....